Alemtuzumab induction combined with reduced maintenance immunosuppression is associated with improved outcomes after lung transplantation: A single centre experience
Fig 1
Trend of estimated glomerular filtration rate after lung transplantation overtime: a) comparison between NI and alemtuzumab, b) comparison between ATG and alemtuzumab.